Abstract
Objectives
To investigate the functional roles of bone marrow stromal cell antigen 2 (BST2) in gastric cancer (GC) cells and its implications in the development of GC patients.
Results
BST2 was frequently overexpressed in GC tissues compared with the adjacent non-tumorous tissues, and high BST2 expression was correlated with tumor stage and lymphatic metastasis. Furthermore, in vitro experiments demonstrated that knockdown of BST2 by siRNA inhibited cell proliferation, induced apoptosis and repressed cell motility in GC cells. In addition, the pro-tumor function of BST2 in GC was mediated partly through the NF-κB signaling.
Conclusion
BST2 possesses the oncogenic potential in GC by regulating the proliferation, apoptosis, and migratory ability of GC cells, thereby BST2 could be a potential therapeutic target for the treatment of GC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bertuccio P et al (2009) Recent patterns in gastric cancer: a global overview. Int J Cancer 125:666–673. https://doi.org/10.1002/ijc.24290
Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB, Iglehart JD (2004) NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA 101:10137–10142. https://doi.org/10.1073/pnas.0403621101
Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z (2009) Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis. BMC cancer 9:102. https://doi.org/10.1186/1471-2407-9-102
Chu D, Zhang Z, Li Y, Zheng J, Dong G, Wang W, Ji G (2011) Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer. Int J Cancer 129:887–895. https://doi.org/10.1002/ijc.25734
Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647–656. https://doi.org/10.1038/nrc883
Cunningham D et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New Engl J Med 355:11–20. https://doi.org/10.1056/NEJMoa055531
De Vita F et al (2014) Clinical management of advanced gastric cancer: the role of new molecular drugs. World J Gastroenterol 20:14537–14558. https://doi.org/10.3748/wjg.v20.i40.14537
Fan YZ, Zhao ZM, Fu JY, Chen CQ, Sun W (2010) Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo. Hepatobiliary Pancreat Dis Int 9:414–422
Fang KH et al (2014) Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer. The Laryngoscope 124:E354–360. https://doi.org/10.1002/lary.24700
Ferlay J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403. https://doi.org/10.1016/j.ejca.2012.12.027
Ferlay J et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–386. https://doi.org/10.1002/ijc.29210
Galao RP, Le Tortorec A, Pickering S, Kueck T, Neil SJ (2012) Innate sensing of HIV-1 assembly by Tetherin induces NFkappaB-dependent proinflammatory responses. Cell Host Microbe 12:633–644. https://doi.org/10.1016/j.chom.2012.10.007
Harada T, Ozaki S (2014) Targeted therapy for HM1.24 (CD317) on multiple myeloma cells. Biomed Res Int 2014:965384. https://doi.org/10.1155/2014/965384
Hochegger H, Takeda S, Hunt T (2008) Cyclin-dependent kinases and cell-cycle transitions: does one fit all? Nat Rev Mol Cell Biol 9:910–916. https://doi.org/10.1038/nrm2510
Kanarek N, Ben-Neriah Y (2012) Regulation of NF-kappaB by ubiquitination and degradation of the IkappaBs. Immunol Rev 246:77–94. https://doi.org/10.1111/j.1600-065X.2012.01098.x
Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18:621–663. https://doi.org/10.1146/annurev.immunol.18.1.621
Kuang CM et al (2017) BST2 confers cisplatin resistance via NF-kappaB signaling in nasopharyngeal cancer. Cell Death Dis 8:e2874. https://doi.org/10.1038/cddis.2017.271
Kupzig S, Korolchuk V, Rollason R, Sugden A, Wilde A, Banting G (2003) Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4:694–709
Maeda S, Omata M (2008) Inflammation and cancer: role of nuclear factor-kappaB activation. Cancer Sci 99:836–842. https://doi.org/10.1111/j.1349-7006.2008.00763.x
Mahauad-Fernandez WD, Okeoma CM (2016) The role of BST-2/Tetherin in host protection and disease manifestation. Immunity, inflammation and disease 4:4–23. https://doi.org/10.1002/iid3.92
Mahauad-Fernandez WD, DeMali KA, Olivier AK, Okeoma CM (2014) Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis. Breast Cancer Res 16:493. https://doi.org/10.1186/s13058-014-0493-8
Marx J (1994) How Cells Cycle Toward Cancer. Science 263:319–321
Mukai S et al (2017) Overexpression of transmembrane protein BST2 is associated with poor survival of patients with esophageal, gastric, or colorectal cancer. Ann Surg Oncol 24:594–602. https://doi.org/10.1245/s10434-016-5100-z
Neil SJ, Zang T, Bieniasz PD (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425–430. https://doi.org/10.1038/nature06553
Ozaki S, Kosaka M, Wakatsuki S, Abe M, Koishihara Y, Matsumoto T (1997) Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24. Blood 90:3179–3186
Pham QT et al (2017) The expression of BTS-2 enhances cell growth and invasiveness in renal cell carcinoma. Anticancer Res 37:2853–2860. https://doi.org/10.21873/anticanres.11637
Qi S et al (2012) ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma. PLoS ONE 7:e38842
Sasaki N et al (2001) Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 7:4136–4142
Sherr CJ (1996) Cancer cell cycles Science 274:1672–1677
Shigematsu Y et al (2017) Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer. Oncol Lett 14:999–1004. https://doi.org/10.3892/ol.2017.6230
Sokolova O, Naumann M (2017) NF-kappaB Signaling in Gastric Cancer Toxins 9 https://doi.org/10.3390/toxins9040119
Tang Y, Lv P, Sun Z, Han L, Zhou W (2016) 14-3-3beta Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells by Modulating Expression of MMP2 and MMP9 through PI3 K/Akt/NF-kappaB Pathway. PLoS ONE 11:e0146070. https://doi.org/10.1371/journal.pone.0146070
Tokarev A, Suarez M, Kwan W, Fitzpatrick K, Singh R, Guatelli J (2013) Stimulation of NF-kappaB activity by the HIV restriction factor BST2. J Virol 87:2046–2057. https://doi.org/10.1128/JVI.02272-12
Vallabhapurapu S, Karin M (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27:693–733. https://doi.org/10.1146/annurev.immunol.021908.132641
Velinov N, Poptodorov G, Gabrovski N, Gabrovski S (2010) The role of matrixmetalloproteinases in the tumor growth and metastasis. Khirurgiia 1:44–49
Wang W et al (2009) HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody. Cancer Immunol Immunother 58:967–976. https://doi.org/10.1007/s00262-008-0612-4
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Liu, W., Cao, Y., Guan, Y. et al. BST2 promotes cell proliferation, migration and induces NF-κB activation in gastric cancer. Biotechnol Lett 40, 1015–1027 (2018). https://doi.org/10.1007/s10529-018-2562-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-018-2562-z